WellDoc Unveils New FDA-Cleared Diabetes App

6-16-2013 9-43-18 PM

San Diego-based WellDoc unveils a patient-centered type 2 diabetes app that provides real-time behavioral, educational, and motivational coaching to help patients stick to their diabetes treatment plans. The new platform, called BlueStar, requires a prescription from a physician. The cost will be covered by prescription benefit plans similar to other prescribed products.

BlueStar helps patients monitor blood glucose testing, assists with diet and exercise decisions, encourages medication compliance, and educates patients on diabetic standards of care such as A1c tests and foot exams.

“Giving patients access to a prescribed mobile therapy that helps tailor treatment to an individual’s needs and their physician’s orders may prove to be a major advancement in diabetes management. In the era of healthcare reform, it’s important that payers recognize that patients must have access to proven, novel digital tools.” Richard Bergenstal M.D. executive director at the International Diabetes Center at Park Nicollet and former president of the American Diabetes Association.

More than 25 million Americans have diabetes, accounting for eight percent of the population and $176 billion in annual costs.

↑ Back to top

Founding Sponsors

Platinum Sponsors